Aspiriant LLC’s Starbucks SBUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $396K | Sell |
4,417
-477
| -10% | -$45.1K | 0.01% | 248 |
|
|
2025
Q4 | $412K | Buy |
4,894
+28
| +0.6% | +$2.36K | 0.01% | 238 |
|
|
2025
Q3 | $412K | Sell |
4,866
-63
| -1% | -$5.64K | 0.01% | 216 |
|
|
2025
Q2 | $452K | Sell |
4,929
-21
| -0.4% | -$1.82K | 0.01% | 210 |
|
|
2025
Q1 | $486K | Buy |
4,950
+305
| +7% | +$31.5K | 0.02% | 192 |
|
|
2024
Q4 | $424K | Sell |
4,645
-99
| -2% | -$9.58K | 0.02% | 204 |
|
|
2024
Q3 | $462K | Sell |
4,744
-47
| -1% | -$4.03K | 0.02% | 191 |
|
|
2024
Q2 | $373K | Sell |
4,791
-748
| -14% | -$60.9K | 0.02% | 209 |
|
|
2024
Q1 | $506K | Buy |
5,539
+211
| +4% | +$19.6K | 0.02% | 197 |
|
|
2023
Q4 | $512K | Sell |
5,328
-52
| -1% | -$5.06K | 0.02% | 187 |
|
|
2023
Q3 | $491K | Buy |
5,380
+644
| +14% | +$63.2K | 0.03% | 181 |
|
|
2023
Q2 | $469K | Buy |
4,736
+7
| +0.1% | +$727 | 0.02% | 182 |
|
|
2023
Q1 | $492K | Buy |
4,729
+672
| +17% | +$69.9K | 0.03% | 177 |
|
|
2022
Q4 | $402K | Sell |
4,057
-1,348
| -25% | -$127K | 0.02% | 193 |
|
|
2022
Q3 | $456K | Buy |
5,405
+55
| +1% | +$4.67K | 0.02% | 175 |
|
|
2022
Q2 | $408K | Sell |
5,350
-30
| -0.6% | -$2.3K | 0.02% | 181 |
|
|
2022
Q1 | $489K | Sell |
5,380
-1,330
| -20% | -$126K | 0.03% | 174 |
|
|
2021
Q4 | $784K | Buy |
6,710
+3,896
| +138% | +$439K | 0.04% | 149 |
|
|
2021
Q3 | $311K | Buy |
2,814
+1
| +0% | +$117 | 0.02% | 195 |
|
|
2021
Q2 | $316K | Sell |
2,813
-31
| -1% | -$3.5K | 0.02% | 195 |
|
|
2021
Q1 | $309K | Buy |
2,844
+232
| +9% | +$24.4K | 0.02% | 177 |
|
|
2020
Q4 | $280K | Buy |
2,612
+176
| +7% | +$16.8K | 0.02% | 178 |
|
|
2020
Q3 | $208K | Sell |
2,436
-408
| -14% | -$32.5K | 0.02% | 207 |
|
|
2020
Q2 | $210K | Sell |
2,844
-394
| -12% | -$29.6K | 0.02% | 173 |
|
|
2020
Q1 | $213K | Sell |
3,238
-713
| -18% | -$57.7K | 0.02% | 174 |
|
|
2019
Q4 | $348K | Buy |
3,951
+44
| +1% | +$3.75K | 0.03% | 163 |
|
|
2019
Q3 | $346K | Sell |
3,907
-474
| -11% | -$43.9K | 0.03% | 168 |
|
|
2019
Q2 | $366K | Buy |
4,381
+9
| +0.2% | +$706 | 0.03% | 169 |
|
|
2019
Q1 | $325K | Sell |
4,372
-544
| -11% | -$37.4K | 0.03% | 174 |
|
|
2018
Q4 | $319K | Buy |
4,916
+705
| +17% | +$44.1K | 0.02% | 180 |
|
|
2018
Q3 | $241K | Sell |
4,211
-1,075
| -20% | -$56.8K | 0.02% | 213 |
|
|
2018
Q2 | $258K | Buy |
5,286
+511
| +11% | +$29K | 0.02% | 219 |
|
|
2018
Q1 | $276K | Buy |
+4,775
| New | +$276K | 0.02% | 199 |
|
|
2017
Q4 | – | Sell |
-5,817
| Closed | -$312K | – | 159 |
|
|
2017
Q3 | $312K | Sell |
5,817
-835
| -13% | -$46.3K | 0.03% | 160 |
|
|
2017
Q2 | $388K | Buy |
6,652
+641
| +11% | +$38.8K | 0.03% | 157 |
|
|
2017
Q1 | $351K | Sell |
6,011
-2,531
| -30% | -$143K | 0.03% | 167 |
|
|
2016
Q4 | $474K | Sell |
8,542
-56
| -0.7% | -$3.1K | 0.04% | 139 |
|
|
2016
Q3 | $466K | Buy |
8,598
+824
| +11% | +$46.1K | 0.05% | 143 |
|
|
2016
Q2 | $422K | Buy |
7,774
+1,494
| +24% | +$84.9K | 0.04% | 145 |
|
|
2016
Q1 | $375K | Buy |
+6,280
| New | +$366K | 0.04% | 145 |
|
Other funds holding SBUX
VCM
VPM
Aspiriant LLC's SBUX Position: Q1 2026 in Review
Aspiriant LLC reduced its Starbucks (SBUX) stake by 9.7% in Q1 2026, selling an estimated $45.1K and leaving 4,417 shares worth $396K. The position accounts for 0.01% of the portfolio, ranked #248.
Aspiriant LLC first reported a position in SBUX in Q1 2016 and has held it in 40 quarters since. The position peaked at $784K in Q4 2021. 2,330 funds tracked by Wall St. Rank hold SBUX as of Q1 2026.
- Aspiriant LLC held 4,417 shares of Starbucks worth $396K as of Q1 2026.
- Aspiriant LLC sold 477 Starbucks shares in Q1 2026, an estimated $45.1K.
- Starbucks made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #248 holding.
- Aspiriant LLC first reported a position in Starbucks in Q1 2016 and has held it in 40 quarters since.
- Aspiriant LLC's Starbucks position peaked at $784K in Q4 2021.
- 2,330 funds tracked by Wall St. Rank held Starbucks as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.